Clinical trial
Blockade of Vascular Potassium Channels During Human Endotoxemia
NCT00185003 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00185003 |
|---|---|
| Title | Blockade of Vascular Potassium Channels During Human Endotoxemia |
| Official title | Blockade of Vascular Potassium Channels During Human Endotoxemia |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | ZonMw: The Netherlands Organisation for Health Research and Development |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Endotoxemia |
| Intervention type | Drug |
| Interventions | endotoxin, Potassium channel blockers: TEA, Quinin, Tolbutamide, L-NMMA |
| Enrollment | 36 |
| Start date | Jan 1, 2003 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 17, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: